1. Home
  2. World
  3. Special seat reserved for Hindus, Sikhs in Afghan Parliament

Special seat reserved for Hindus, Sikhs in Afghan Parliament

safia@coastaldigest.com (PTI)
September 4, 2013

afghanistanprayers

Kabul, Sep 4: President Hamid Karzai today issued a historic legislative decree reserving a special seat for Sikh and Hindu Afghan nationals in the lower house of the country's Parliament.

Karzai, through the legislative decree, approved the Cabinet amendments of August 26, 2013, to the Election Law, designating a particular seat in the Wolesi Jirga for Sikh and Hindu nationals, according to a statement from the office of the President.

In the Presidential decree, Karzai assigned the Ministers of Justice and Parliamentary Affairs to submit the decree within 30 days after the National Assembly of Afghanistan resumes its first session.

The decree further says that the amendments to the Election Law came into force upon signature by the President and shall be published along with the relevant Cabinet resolution in the official gazette.

The National Assembly of Afghanistan is a bicameral body, comprising two chambers, Wolesi Jirga or the lower house with 249 seats and Meshrano Jirga or the Upper House with 102 seats.

The reserved seat has been designated to the lower house which will now have 250 members.

Karzai's decision has come after lawmakers declined to reserve a special seat for Hindus and Sikhs in the law.

The Afghan President has the power to issue legislative decrees when the Parliament is on vacation.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 1,2020

Washington, May 1: The United States on Thursday recorded 29,625 new coronavirus cases, and 2,035 deaths in the last 24 hours, according to Johns Hopkins University.

The total number of coronavirus cases has reached 1,069,534 and the death toll stands at 63,001, CNN reported.

The novel coronavirus has infected more than 3.2 million people and killed at least 233,000 globally, according to Johns Hopkins University.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 27,2020

Geneva, May 27: The number of confirmed cases of COVID-19 worldwide has increased by nearly 100,000 over the past 24 hours to surpass 5.4 million, the World Health Organisation (WHO) said.

According to the WHO, the global case tally currently stands at 5,404,512 -- a rise by 99,780 over the past day.

The death count worldwide amounts to 343,514 -- an increase by 1,486.

Most cases of infection are recorded in the Americas -- 2,454,452, with 143,739 deaths.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 20,2020

Paris, Jul 20: Two coronavirus vaccine candidates have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors said on Monday.

The first trial among more than 1,000 adults in Britain found that the vaccine induced "strong antibody and T cell immune responses" against the novel coronavirus.

A separate trial in China involving more than 500 people showed most had developed widespread antibody immune response.

The studies, published in The Lancet medical journal, constitute a major step on the road towards a COVID-19 vaccine that is effective and safe for widespread use.

The authors of the studies said that they encountered few adverse side-effects from the vaccine candidates.

However, they cautioned that more research was needed, particularly among older adults, who are disproportionately at risk of dying of COVID-19.

Co-author Sarah Gilbert from the University of Oxford said the results "hold promise".

"If our vaccine is effective, it is a promising option as these types of vaccine can be manufactured at large scale."

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.